pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
(aeruginascin + baeocystin + psilocybin) · news · pharmadog
← back to (aeruginascin + baeocystin + psilocybin)
News mentioning (aeruginascin + baeocystin + psilocybin)
13
stories
2d
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
8d
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
biospace
12d
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
biospace
14d
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
fiercebiotech
16d
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
biopharma dive
16d
Lilly makes up to $3.8B psychedelics play in AtaiBeckley takeover
biospace
16d
J&J sees Spravato sales surge as psychedelic competitors loom
biospace
25d
Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filing
endpoints
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
May 6, 26
Opinion: Trump’s executive order on psychedelics is the right move. But is my field ready for it?
stat
May 1, 26
Opinion: The psychedelic revolution is leaving behind people of color
stat
Apr 30, 26
Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier
stat
Apr 27, 26
What’s the true risk for eating disorders with GLP-1s?
stat
